GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $0 | – | 1,600 | +128.6% | 0.00% | – |
Q1 2021 | $0 | – | 700 | -12.5% | 0.00% | – |
Q4 2020 | $0 | – | 800 | +33.3% | 0.00% | – |
Q3 2020 | $0 | – | 600 | -14.3% | 0.00% | – |
Q2 2020 | $0 | -100.0% | 700 | -87.7% | 0.00% | – |
Q1 2020 | $1,000 | -66.7% | 5,700 | +42.5% | 0.00% | – |
Q4 2019 | $3,000 | – | 4,000 | +3900.0% | 0.00% | – |
Q3 2019 | $0 | – | 100 | 0.0% | 0.00% | – |
Q2 2019 | $0 | -100.0% | 100 | -75.0% | 0.00% | – |
Q1 2019 | $3,000 | -96.2% | 400 | -96.6% | 0.00% | -100.0% |
Q4 2018 | $80,000 | -7.0% | 11,700 | +4.5% | 0.01% | +16.7% |
Q3 2018 | $86,000 | +8500.0% | 11,200 | +11100.0% | 0.01% | – |
Q2 2018 | $1,000 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|